https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-75262003000600010
EFICACIA DE LA DEXAMETASONA EN SINDROME HELLP

El síndrome Hellp (SH) se puede          presentar ante, intra o postparto (1), el 69% se presenta          ante y el 31% postparto (2) y con frecuencia complica          a embarazos de pretérmino o antes de 28 semanas, el 41% ocurre          antes de las 31 semanas (3) y por lo tanto en portadores          de feto inmaduro. La interrupción de un embarazo con SH de 28 semanas          se acompaña de una mortalidad perinatal de 22% (4),          en cambio la mortalidad en iguales condiciones en embarazos de más          de 29 semanas varía entre 0 y 5% (4). La relación          directa a menor edad gestacional mayor mortalidad perinatal en el SH ha          originado desacuerdo en cuanto a tratamiento (5): algunos          autores (6-8) indican el parto inmediato          para prevenir las graves complicaciones maternas (9)          en cambio otros sugieren un tratamiento conservador en un intento para          conseguir una mayor maduración pulmonar (10,          11); Van Dam (5) señala que          el tratamiento conservador solo sería posible siempre que no exista          coagulación intravascular diseminada (diagnóstico precoz)          debido al peor pronóstico materno-fetal. Ante esta realidad, la          indicación, actual es intentar prolongar la gestación siempre          que no halla contraindicación materna o fetal (1),          pero siempre que al mismo tiempo se pueda mejorar, detener o revertir          la evolución clínica y bioquímica del SH (1,          12), y esto se ha intentado al administrar Betametasona          y Dexametasona a diferentes dosis y por vía E.V. o I.M. (1).          Los estudios con corticoides se han realizado en pacientes con Preeclampsia          y SH (1, 12-15) pero          sólo en un número limitado de pacientes que presentan hipertensión          crónica por largo tiempo (1, 16),          y por esto se considera de interés presentar la evolución          y respuesta al tratamiento con Dexametasona en una gestante de 26 semanas          hipertensa crónica con preeclampsia sobreagregada y S. Hellp. 

CASO CLINICO 

Paciente M.A.O.L. Edad: 39 años.          

Antecedentes generales: HTA crónica          diagnosticada en 1990, en tratamiento con Propanolol 80 mg/día,          Enalapril 15 mg/día, Hidroclorotiazida 50 mg/día. Alergia          a Cotrimoxazol. 

Antecedentes obstétricos: G3P2A0,          M2-2CCA, FUR: 24/05/03. Controlada en consultorio hasta las 20 semanas          de gestación con cifras tensionales normales y proteinuria cualitativa          negativa. 

Ingresa el 11/11/03 al policlínico          de Feto de Alto Riesgo del hospital Dr. Luis Tisné Brousse, derivada          desde consultorio por cifras tensionales elevadas y cefalea. El control          señala presión arterial 190/110 mmHg, y la proteinuria cualitativa          se calcula en (+++). Se solicitan exámenes y se hospitaliza el          12/11/03 en sala de Alto Riesgo Obstétrico de este hospital. 

Se realizan exámenes de laboratorio          dos a tres veces por semana (Tabla I) y se evalúa          en forma seriada la unidad feto-placentaria que señala disminución          del crecimiento fetal a partir de las 25 semanas y el estudio Doppler          que indica aumento de la resistencia de la arteria umbilical (0,91). La          evaluación clínica y bioquímica de la paciente muestra          que la hipertensión crónica severa, se suma una preeclampsia          con compromiso de laboratorio progresivo, al cual se le agrega posteriormente          alteraciones compatibles con síndrome Hellp (Tabla          I). La paciente siempre se mantiene clínicamente estable con          compromiso moderado de la unidad feto-placentaria. 

   

Al ingreso se realiza maduración          con Betametasona 12 mg cada 24 horas (dos dosis), el tratamiento hipotensor          se inicia con Metildopa 2000 mg/día, Nifedipino 10 mg/día,          posteriormente y debido a cifras tensionales ³200/120 mmHg se agrega          Labetalol vía oral entre 600 a 800 mg/día (200 mg cada 6          a 8 horas), con lo que se logra mantener cifras tensionales de 180-190          de sistólica y 100-105 de diastólica. Además la paciente          recibe Alprazolam 0,5 mg/día y Sulfato de Magnesio 5 g en bolo          y 1 g/hora durante 24 horas (fleboclisis). 

Debido al compromiso progresivo de la paciente,          el día 23 de noviembre se decide iniciar tratamiento con Dexametasona          endovenosa a dosis de 10 mg cada 12 horas con el fin de detener o revertir          la evolución del síndrome Hellp. Al día siguiente          se interrumpe el embarazo mediante operación cesárea, con          los siguientes diagnósticos: 

Multípara de 2, embarazo de 26+1          semanas, hipertensión crónica severa, preeclampsia sobreagregada,          Síndrome Hellp y RCIU. Se obtiene un RN de 590 g (PEG), sexo masculino,          Apgar 4-7 que evoluciona con membrana hialina y a las 24 horas clínicamente          se evidencia un cuadro compatible con perforación intestinal, trasladándose          al 4º día al Hospital Luis Calvo Mackenna para tratamiento          quirúrgico. La madre evoluciona clínicamente estable, manejándose          con Atenolol 50 mg/día e Hidralazina 200 mg/día, se mantiene          la Dexametasona por 48 h EV. Desde el punto de vista bioquímico          continúa con disminución de las transaminasas, la oxaloacética          más que la pirúvica hasta la normalización de ambas,          la deshidrogenasa láctica también disminuye progresivamente          hasta normalizarse y las plaquetas recuperaron su valor normal. Es dada          de alta al 5º día con cifras tensionales de 140/90 clínicamente          estable, con tratamiento antihipertensivo con Atenolol 50 mg/día.          

COMENTARIO 

El diagnóstico de preeclampsia sobreagregada          a hipertensión crónica no ofrece dudas por los antecedentes,          la evolución clínica y bioquímica y el diagnóstico          de síndrome Hellp por la hemólisis demostrada por los niveles          de Deshidrogenasa láctica (LDH) mayores de 600 UI/L, por la disfunción          hepática evidenciada por la elevación de las enzimas hepáticas          transaminasas oxaloacética (SGOT/AST) y pirúvica (SGPT/ALT)          (Tabla I y Figuras 1, 2          y 3) y por la trombocitopenia menor a 100.000 x mm.          La decisión de administrar Dexametasona ante parto se hizo con          el fin de estabilizar el síndrome Hellp, y se basó en los          múltiples estudios y experiencias de varios años, que confirman          los beneficios de administrar corticoides en el tratamiento de este síndrome          y que no se acompaña de mayores riesgos para la madre, el feto          y al parecer tampoco para el RN (1, 16);          no se usó Betametasona por la mayor eficacia demostrada por la          Dexametasona (17). El segundo punto que se analizó          antes de administrar este corticoides es que no hubiera contraindicaicón          y para eso se consideró los parámetros excluyentes señalados          por Isler (1) y que no incluye la hipertensión          crónica previa (esta paciente es hipertensa desde 1990). 

  

 

  

 

  

 

Después de la administracion de          dexametasona, se hizo determinaciones seriadas a las 8 y luego a las 12          horas de enzimas hepáticas (SGOT y SGPT), LDH y recuento de plaquetas,          también determinaciones de creatinina, ácido úrico          y control cada 4 horas de signos vitales, cuadro clínico y además          control de diuresis, determinación de proteinuria, calciuria y          creatinuria en orina de 24 horas. Los resultados de estos estudios señalan:          descenso rápido y persistente de enzimas hepática (preferentemente          SGOT), también disminución de LDH y recuperación          del recuento de plaquetas 

En cuanto a como actúan los corticoides          administrados en altas dosis ante o postparto para estabilizar el síndrome          Hellp, se han sugerido alguna hipótesis y la acción podría          ser a través de las plaquetas: modificación de la adhesión,          activación o a nivel del bazo (no secuestro) y también se          han sugerido posibles modificaciones a nivel de la microvasculatura y          endotelio (1). 

De acuerdo a la evolución del síndrome          Hellp en esta paciente, se considera que si no existe contraindicación          materna o fetal previa a la administración de dexametasona (1)          y si no hay compromiso de la madre o del producto durante el tratamiento          expectante o conservador (1) y además si existe          buena respuesta al tratamiento con corticoides, el intervalo de tiempo          entre la administración y la interrupción del embarazo puede          ser mayor a las 26 horas (tiempo de intervalo en esta observación)          y a las 30 horas promedio (1, 16) señaladas          en otras publicaciones. 

 

BIBLIOGRAFIA 

 1. Isler Ch, Scott P,          Magann F: A prospective, randomized trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hello syndrome. Am J          Obstet Gynecol 2001; 184-1332-9.         [ Links ] 2. Sibai B: The Hellp          syndrome (hemolysis, elevated liver enzumes, and low platelets): Much          a do about nothing? Am J Obstet Gynecol 1990; 162: 311-6.         [ Links ] 3. Sibai B, Taslimi M,          El-Nazer A: Maternal-perinatal outcome associated with the syndrome of          hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia.          Am J Obstet Gynecol 1986; 155: 501-9.         [ Links ] 4. Abramovici D, Friedman          S, Mercer B: Neonatal outcome in severe preeclampsia at 24 to 26 weeks          gestation: Does the Hellp syndrome matter. Am J Obstet Gynecol 1999; 180:          221-5.         [ Links ] 5. Van Dam P, Renier M,          Baekelandt M: Disseminated Intravascular Coagulation and the Syndrome          of Hemolysis, Elevated Liver Enzymes, and low Platelets in severe preeclampsia.          Obstet Gynecol 1989; 73: 97.         [ Links ] 6. Weinstein L: Syndrome          of hemolysis, elevated liver enzymes, and low platelet count. A severe          consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142:          159-67.         [ Links ] 7. Oian P, Abzholm J:          Hellp-syndrome: A serious complication of Hypertension in pregnancy. Acta          Obstet Gynecol Scand 1984; 63: 727-9.         [ Links ] 8. Weinstein L: Preeclampsia/eclampsia          with hemolysis elevated liver enzymes and thrombocytopenia. Obstet Gynecol          1985; 66: 657-60.         [ Links ] 9. Sibai B, Ramadan M:          Acute renal failure in pregnancies complicated by hemolysis, elevated          liver enzymes, and low platelets. Am J Obstet Gynecol 1993; 168: 1682-09.                  [ Links ]10. Mackenna J, Doves,          Brame RJ: Preeclampsia associated with hemolysis, elevated lier enzymes          and low platelets. An obstetric emergency? Obstet Gynecol 1983; 62: 751-4.                  [ Links ]11. Clark SL, Phelan JR,          Allen SH et al: Antepartum reversal of hematologic abnormalities with          the Hellp-syndrome. J Reprod Med 1886; 31: 70-2.             [ Links ]12. Magann E, Kenneth          P, Meydrech E: Postpartum corticosteroids: Accelerated recovery from the          syndrome of hemolysis, elevated liver enzymes, and low platelets (Hellp).          Am J Obstet Gynecol 1994; 171: 1154-8.         [ Links ]13. Magann E, Bass D,          Chauham S: Antepartum corticosteroids: Disease stabilization in patients          with the syndrome of hemolysis, elevated liver enzymes, and low platelets          (Hellp). Am J Obstet Gynecol 1994; 171: 1148-3.         [ Links ]14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

 2. Sibai B: The Hellp          syndrome (hemolysis, elevated liver enzumes, and low platelets): Much          a do about nothing? Am J Obstet Gynecol 1990; 162: 311-6.         [ Links ] 3. Sibai B, Taslimi M,          El-Nazer A: Maternal-perinatal outcome associated with the syndrome of          hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia.          Am J Obstet Gynecol 1986; 155: 501-9.         [ Links ] 4. Abramovici D, Friedman          S, Mercer B: Neonatal outcome in severe preeclampsia at 24 to 26 weeks          gestation: Does the Hellp syndrome matter. Am J Obstet Gynecol 1999; 180:          221-5.         [ Links ] 5. Van Dam P, Renier M,          Baekelandt M: Disseminated Intravascular Coagulation and the Syndrome          of Hemolysis, Elevated Liver Enzymes, and low Platelets in severe preeclampsia.          Obstet Gynecol 1989; 73: 97.         [ Links ] 6. Weinstein L: Syndrome          of hemolysis, elevated liver enzymes, and low platelet count. A severe          consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142:          159-67.         [ Links ] 7. Oian P, Abzholm J:          Hellp-syndrome: A serious complication of Hypertension in pregnancy. Acta          Obstet Gynecol Scand 1984; 63: 727-9.         [ Links ] 8. Weinstein L: Preeclampsia/eclampsia          with hemolysis elevated liver enzymes and thrombocytopenia. Obstet Gynecol          1985; 66: 657-60.         [ Links ] 9. Sibai B, Ramadan M:          Acute renal failure in pregnancies complicated by hemolysis, elevated          liver enzymes, and low platelets. Am J Obstet Gynecol 1993; 168: 1682-09.                  [ Links ]10. Mackenna J, Doves,          Brame RJ: Preeclampsia associated with hemolysis, elevated lier enzymes          and low platelets. An obstetric emergency? Obstet Gynecol 1983; 62: 751-4.                  [ Links ]11. Clark SL, Phelan JR,          Allen SH et al: Antepartum reversal of hematologic abnormalities with          the Hellp-syndrome. J Reprod Med 1886; 31: 70-2.             [ Links ]12. Magann E, Kenneth          P, Meydrech E: Postpartum corticosteroids: Accelerated recovery from the          syndrome of hemolysis, elevated liver enzymes, and low platelets (Hellp).          Am J Obstet Gynecol 1994; 171: 1154-8.         [ Links ]13. Magann E, Bass D,          Chauham S: Antepartum corticosteroids: Disease stabilization in patients          with the syndrome of hemolysis, elevated liver enzymes, and low platelets          (Hellp). Am J Obstet Gynecol 1994; 171: 1148-3.         [ Links ]14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

 3. Sibai B, Taslimi M,          El-Nazer A: Maternal-perinatal outcome associated with the syndrome of          hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia.          Am J Obstet Gynecol 1986; 155: 501-9.         [ Links ] 4. Abramovici D, Friedman          S, Mercer B: Neonatal outcome in severe preeclampsia at 24 to 26 weeks          gestation: Does the Hellp syndrome matter. Am J Obstet Gynecol 1999; 180:          221-5.         [ Links ] 5. Van Dam P, Renier M,          Baekelandt M: Disseminated Intravascular Coagulation and the Syndrome          of Hemolysis, Elevated Liver Enzymes, and low Platelets in severe preeclampsia.          Obstet Gynecol 1989; 73: 97.         [ Links ] 6. Weinstein L: Syndrome          of hemolysis, elevated liver enzymes, and low platelet count. A severe          consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142:          159-67.         [ Links ] 7. Oian P, Abzholm J:          Hellp-syndrome: A serious complication of Hypertension in pregnancy. Acta          Obstet Gynecol Scand 1984; 63: 727-9.         [ Links ] 8. Weinstein L: Preeclampsia/eclampsia          with hemolysis elevated liver enzymes and thrombocytopenia. Obstet Gynecol          1985; 66: 657-60.         [ Links ] 9. Sibai B, Ramadan M:          Acute renal failure in pregnancies complicated by hemolysis, elevated          liver enzymes, and low platelets. Am J Obstet Gynecol 1993; 168: 1682-09.                  [ Links ]10. Mackenna J, Doves,          Brame RJ: Preeclampsia associated with hemolysis, elevated lier enzymes          and low platelets. An obstetric emergency? Obstet Gynecol 1983; 62: 751-4.                  [ Links ]11. Clark SL, Phelan JR,          Allen SH et al: Antepartum reversal of hematologic abnormalities with          the Hellp-syndrome. J Reprod Med 1886; 31: 70-2.             [ Links ]12. Magann E, Kenneth          P, Meydrech E: Postpartum corticosteroids: Accelerated recovery from the          syndrome of hemolysis, elevated liver enzymes, and low platelets (Hellp).          Am J Obstet Gynecol 1994; 171: 1154-8.         [ Links ]13. Magann E, Bass D,          Chauham S: Antepartum corticosteroids: Disease stabilization in patients          with the syndrome of hemolysis, elevated liver enzymes, and low platelets          (Hellp). Am J Obstet Gynecol 1994; 171: 1148-3.         [ Links ]14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

 4. Abramovici D, Friedman          S, Mercer B: Neonatal outcome in severe preeclampsia at 24 to 26 weeks          gestation: Does the Hellp syndrome matter. Am J Obstet Gynecol 1999; 180:          221-5.         [ Links ] 5. Van Dam P, Renier M,          Baekelandt M: Disseminated Intravascular Coagulation and the Syndrome          of Hemolysis, Elevated Liver Enzymes, and low Platelets in severe preeclampsia.          Obstet Gynecol 1989; 73: 97.         [ Links ] 6. Weinstein L: Syndrome          of hemolysis, elevated liver enzymes, and low platelet count. A severe          consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142:          159-67.         [ Links ] 7. Oian P, Abzholm J:          Hellp-syndrome: A serious complication of Hypertension in pregnancy. Acta          Obstet Gynecol Scand 1984; 63: 727-9.         [ Links ] 8. Weinstein L: Preeclampsia/eclampsia          with hemolysis elevated liver enzymes and thrombocytopenia. Obstet Gynecol          1985; 66: 657-60.         [ Links ] 9. Sibai B, Ramadan M:          Acute renal failure in pregnancies complicated by hemolysis, elevated          liver enzymes, and low platelets. Am J Obstet Gynecol 1993; 168: 1682-09.                  [ Links ]10. Mackenna J, Doves,          Brame RJ: Preeclampsia associated with hemolysis, elevated lier enzymes          and low platelets. An obstetric emergency? Obstet Gynecol 1983; 62: 751-4.                  [ Links ]11. Clark SL, Phelan JR,          Allen SH et al: Antepartum reversal of hematologic abnormalities with          the Hellp-syndrome. J Reprod Med 1886; 31: 70-2.             [ Links ]12. Magann E, Kenneth          P, Meydrech E: Postpartum corticosteroids: Accelerated recovery from the          syndrome of hemolysis, elevated liver enzymes, and low platelets (Hellp).          Am J Obstet Gynecol 1994; 171: 1154-8.         [ Links ]13. Magann E, Bass D,          Chauham S: Antepartum corticosteroids: Disease stabilization in patients          with the syndrome of hemolysis, elevated liver enzymes, and low platelets          (Hellp). Am J Obstet Gynecol 1994; 171: 1148-3.         [ Links ]14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

 5. Van Dam P, Renier M,          Baekelandt M: Disseminated Intravascular Coagulation and the Syndrome          of Hemolysis, Elevated Liver Enzymes, and low Platelets in severe preeclampsia.          Obstet Gynecol 1989; 73: 97.         [ Links ] 6. Weinstein L: Syndrome          of hemolysis, elevated liver enzymes, and low platelet count. A severe          consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142:          159-67.         [ Links ] 7. Oian P, Abzholm J:          Hellp-syndrome: A serious complication of Hypertension in pregnancy. Acta          Obstet Gynecol Scand 1984; 63: 727-9.         [ Links ] 8. Weinstein L: Preeclampsia/eclampsia          with hemolysis elevated liver enzymes and thrombocytopenia. Obstet Gynecol          1985; 66: 657-60.         [ Links ] 9. Sibai B, Ramadan M:          Acute renal failure in pregnancies complicated by hemolysis, elevated          liver enzymes, and low platelets. Am J Obstet Gynecol 1993; 168: 1682-09.                  [ Links ]10. Mackenna J, Doves,          Brame RJ: Preeclampsia associated with hemolysis, elevated lier enzymes          and low platelets. An obstetric emergency? Obstet Gynecol 1983; 62: 751-4.                  [ Links ]11. Clark SL, Phelan JR,          Allen SH et al: Antepartum reversal of hematologic abnormalities with          the Hellp-syndrome. J Reprod Med 1886; 31: 70-2.             [ Links ]12. Magann E, Kenneth          P, Meydrech E: Postpartum corticosteroids: Accelerated recovery from the          syndrome of hemolysis, elevated liver enzymes, and low platelets (Hellp).          Am J Obstet Gynecol 1994; 171: 1154-8.         [ Links ]13. Magann E, Bass D,          Chauham S: Antepartum corticosteroids: Disease stabilization in patients          with the syndrome of hemolysis, elevated liver enzymes, and low platelets          (Hellp). Am J Obstet Gynecol 1994; 171: 1148-3.         [ Links ]14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

 6. Weinstein L: Syndrome          of hemolysis, elevated liver enzymes, and low platelet count. A severe          consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142:          159-67.         [ Links ] 7. Oian P, Abzholm J:          Hellp-syndrome: A serious complication of Hypertension in pregnancy. Acta          Obstet Gynecol Scand 1984; 63: 727-9.         [ Links ] 8. Weinstein L: Preeclampsia/eclampsia          with hemolysis elevated liver enzymes and thrombocytopenia. Obstet Gynecol          1985; 66: 657-60.         [ Links ] 9. Sibai B, Ramadan M:          Acute renal failure in pregnancies complicated by hemolysis, elevated          liver enzymes, and low platelets. Am J Obstet Gynecol 1993; 168: 1682-09.                  [ Links ]10. Mackenna J, Doves,          Brame RJ: Preeclampsia associated with hemolysis, elevated lier enzymes          and low platelets. An obstetric emergency? Obstet Gynecol 1983; 62: 751-4.                  [ Links ]11. Clark SL, Phelan JR,          Allen SH et al: Antepartum reversal of hematologic abnormalities with          the Hellp-syndrome. J Reprod Med 1886; 31: 70-2.             [ Links ]12. Magann E, Kenneth          P, Meydrech E: Postpartum corticosteroids: Accelerated recovery from the          syndrome of hemolysis, elevated liver enzymes, and low platelets (Hellp).          Am J Obstet Gynecol 1994; 171: 1154-8.         [ Links ]13. Magann E, Bass D,          Chauham S: Antepartum corticosteroids: Disease stabilization in patients          with the syndrome of hemolysis, elevated liver enzymes, and low platelets          (Hellp). Am J Obstet Gynecol 1994; 171: 1148-3.         [ Links ]14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

 7. Oian P, Abzholm J:          Hellp-syndrome: A serious complication of Hypertension in pregnancy. Acta          Obstet Gynecol Scand 1984; 63: 727-9.         [ Links ] 8. Weinstein L: Preeclampsia/eclampsia          with hemolysis elevated liver enzymes and thrombocytopenia. Obstet Gynecol          1985; 66: 657-60.         [ Links ] 9. Sibai B, Ramadan M:          Acute renal failure in pregnancies complicated by hemolysis, elevated          liver enzymes, and low platelets. Am J Obstet Gynecol 1993; 168: 1682-09.                  [ Links ]10. Mackenna J, Doves,          Brame RJ: Preeclampsia associated with hemolysis, elevated lier enzymes          and low platelets. An obstetric emergency? Obstet Gynecol 1983; 62: 751-4.                  [ Links ]11. Clark SL, Phelan JR,          Allen SH et al: Antepartum reversal of hematologic abnormalities with          the Hellp-syndrome. J Reprod Med 1886; 31: 70-2.             [ Links ]12. Magann E, Kenneth          P, Meydrech E: Postpartum corticosteroids: Accelerated recovery from the          syndrome of hemolysis, elevated liver enzymes, and low platelets (Hellp).          Am J Obstet Gynecol 1994; 171: 1154-8.         [ Links ]13. Magann E, Bass D,          Chauham S: Antepartum corticosteroids: Disease stabilization in patients          with the syndrome of hemolysis, elevated liver enzymes, and low platelets          (Hellp). Am J Obstet Gynecol 1994; 171: 1148-3.         [ Links ]14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

 8. Weinstein L: Preeclampsia/eclampsia          with hemolysis elevated liver enzymes and thrombocytopenia. Obstet Gynecol          1985; 66: 657-60.         [ Links ] 9. Sibai B, Ramadan M:          Acute renal failure in pregnancies complicated by hemolysis, elevated          liver enzymes, and low platelets. Am J Obstet Gynecol 1993; 168: 1682-09.                  [ Links ]10. Mackenna J, Doves,          Brame RJ: Preeclampsia associated with hemolysis, elevated lier enzymes          and low platelets. An obstetric emergency? Obstet Gynecol 1983; 62: 751-4.                  [ Links ]11. Clark SL, Phelan JR,          Allen SH et al: Antepartum reversal of hematologic abnormalities with          the Hellp-syndrome. J Reprod Med 1886; 31: 70-2.             [ Links ]12. Magann E, Kenneth          P, Meydrech E: Postpartum corticosteroids: Accelerated recovery from the          syndrome of hemolysis, elevated liver enzymes, and low platelets (Hellp).          Am J Obstet Gynecol 1994; 171: 1154-8.         [ Links ]13. Magann E, Bass D,          Chauham S: Antepartum corticosteroids: Disease stabilization in patients          with the syndrome of hemolysis, elevated liver enzymes, and low platelets          (Hellp). Am J Obstet Gynecol 1994; 171: 1148-3.         [ Links ]14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

 9. Sibai B, Ramadan M:          Acute renal failure in pregnancies complicated by hemolysis, elevated          liver enzymes, and low platelets. Am J Obstet Gynecol 1993; 168: 1682-09.                  [ Links ]10. Mackenna J, Doves,          Brame RJ: Preeclampsia associated with hemolysis, elevated lier enzymes          and low platelets. An obstetric emergency? Obstet Gynecol 1983; 62: 751-4.                  [ Links ]11. Clark SL, Phelan JR,          Allen SH et al: Antepartum reversal of hematologic abnormalities with          the Hellp-syndrome. J Reprod Med 1886; 31: 70-2.             [ Links ]12. Magann E, Kenneth          P, Meydrech E: Postpartum corticosteroids: Accelerated recovery from the          syndrome of hemolysis, elevated liver enzymes, and low platelets (Hellp).          Am J Obstet Gynecol 1994; 171: 1154-8.         [ Links ]13. Magann E, Bass D,          Chauham S: Antepartum corticosteroids: Disease stabilization in patients          with the syndrome of hemolysis, elevated liver enzymes, and low platelets          (Hellp). Am J Obstet Gynecol 1994; 171: 1148-3.         [ Links ]14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

10. Mackenna J, Doves,          Brame RJ: Preeclampsia associated with hemolysis, elevated lier enzymes          and low platelets. An obstetric emergency? Obstet Gynecol 1983; 62: 751-4.                  [ Links ]11. Clark SL, Phelan JR,          Allen SH et al: Antepartum reversal of hematologic abnormalities with          the Hellp-syndrome. J Reprod Med 1886; 31: 70-2.             [ Links ]12. Magann E, Kenneth          P, Meydrech E: Postpartum corticosteroids: Accelerated recovery from the          syndrome of hemolysis, elevated liver enzymes, and low platelets (Hellp).          Am J Obstet Gynecol 1994; 171: 1154-8.         [ Links ]13. Magann E, Bass D,          Chauham S: Antepartum corticosteroids: Disease stabilization in patients          with the syndrome of hemolysis, elevated liver enzymes, and low platelets          (Hellp). Am J Obstet Gynecol 1994; 171: 1148-3.         [ Links ]14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

11. Clark SL, Phelan JR,          Allen SH et al: Antepartum reversal of hematologic abnormalities with          the Hellp-syndrome. J Reprod Med 1886; 31: 70-2.             [ Links ]12. Magann E, Kenneth          P, Meydrech E: Postpartum corticosteroids: Accelerated recovery from the          syndrome of hemolysis, elevated liver enzymes, and low platelets (Hellp).          Am J Obstet Gynecol 1994; 171: 1154-8.         [ Links ]13. Magann E, Bass D,          Chauham S: Antepartum corticosteroids: Disease stabilization in patients          with the syndrome of hemolysis, elevated liver enzymes, and low platelets          (Hellp). Am J Obstet Gynecol 1994; 171: 1148-3.         [ Links ]14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

12. Magann E, Kenneth          P, Meydrech E: Postpartum corticosteroids: Accelerated recovery from the          syndrome of hemolysis, elevated liver enzymes, and low platelets (Hellp).          Am J Obstet Gynecol 1994; 171: 1154-8.         [ Links ]13. Magann E, Bass D,          Chauham S: Antepartum corticosteroids: Disease stabilization in patients          with the syndrome of hemolysis, elevated liver enzymes, and low platelets          (Hellp). Am J Obstet Gynecol 1994; 171: 1148-3.         [ Links ]14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

13. Magann E, Bass D,          Chauham S: Antepartum corticosteroids: Disease stabilization in patients          with the syndrome of hemolysis, elevated liver enzymes, and low platelets          (Hellp). Am J Obstet Gynecol 1994; 171: 1148-3.         [ Links ]14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

14. Martin J Jr, Perry          K, Blake P: Better maternal outcomes are achieved with dexamethasone therapy          for postpartum Hellp (hemolysis, elevated liver enzymes, and thrombocytopenia)          syndrome. Am J Obstet Gynecol 1997; 177: 1011-7.         [ Links ]15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

15. O'Brien J, Milligan          D, Barton J: Impact of high dose corticosteroid therapy for patients with          Hellp (hemolysis, elevated liver enzymes, and platelets count) syndrome.          Am J Obstet Gynecol 2000; 183: 921-4.         [ Links ]16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

16. Martin J Jr, Thigpen          B, Rose C: Maternal benefit of high dose intravenous corticosteroid therapy          for Hellp syndrome. Am J Obstet Gynecol 2003; 189: 830-4.         [ Links ]17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

17. Isler Ch, Barrilleaux          P, Magann F: A prospective, trial comparing the efficacy of dexamethasone          and betamethasone for the treatment of antepartum Hellp (hemolysis, elevated          liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2003;          184: 1332-9.         [ Links ]*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003. 

*Trabajo recibido en diciembre          de 2003 y aceptado para publicación por el Comité Editor          en diciembre de 2003.